FDA Adverse Event Injury Summary report: N

CLARIVEIN IC INFUSION CATHETER

MDR report key: 6944088 · Received October 12, 2017

Report

Report Number
3005831739-2017-00012
Event Type
Injury
Date Received
October 12, 2017
Date of Event
August 25, 2017
Report Date
October 11, 2017
Manufacturer
VASCULAR INSIGHTS LLC
Product Code
KRA
UDI-DI
10854339004027
PMA / PMN Number
K071468
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE CLARIVEIN DEVICE WAS NOT AVAILABLE FOR INVESTIGATION. THERE WERE NO ISSUES CITED WITH DEVICE PERFORMANCE. POTENTIAL ADVERSE EFFECTS THAT MIGHT BE ASSOCIATED WITH THE CLARIVEIN® DEVICE ARE SIMILAR TO THOSE ASSOCIATED WITH ANY INTERVENTIONAL VASCULAR PROCEDURE. THE IFU PROVIDED WITH THE CLARIVEIN DEVICE LISTS THE POTENTIAL ADVERSE EVENTS THAT MIGHT BE ENCOUNTERED DURING A PERIPHERAL VASCULATURE INFUSION PROCEDURE USING THE CLARIVEIN® IC AS WELL AS INSTRUCTS THE USER TO CONSULT LABELING OF AGENTS TO BE DELIVERED PRIOR TO INFUSION.

Description of Event or Problem · 1

DURING A ROUTINE FOLLOW-UP RIGHT LEG, POPLITEAL AND DISTAL FEMORAL VEIN DVT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
724020 CLARIVEIN IC INFUSION CATHETER CLARIVEIN IC INFUSION CATHETER KRA VASCULAR INSIGHTS LLC 65-018-E4S BM651404816I 10854339004027

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention